Loan Capital Changement Date
AbbVie USD 55.63B 181M 2023-09
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.06M 0 2022-09
ALKERMES USD 288.37M 635K 2023-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amgen USD 63.17B 4.13B 2023-12
Biogen USD 6.79B 1.8M 2023-12
BioMarin Pharmaceutical USD 593.1M 509K 2023-12
Cytokinetics USD 607.37M 1.65M 2023-12
Dynavax Technologies USD 222.7M 283K 2023-12
Enanta Pharmaceuticals USD 1.42M 0 2023-09
Exelixis USD 0 0 2022-03
Gilead Sciences USD 23.19B 1.98B 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Incyte USD 29.16M 303K 2023-12
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 61.05B 308M 2023-09
Prothena USD 0 0 2022-06
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Repligen USD 0 0 2022-06
Rigel Pharmaceuticals USD 59.66M 85K 2023-09
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Teva Pharmaceutical Industries USD 18.5B 203M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09
Xoma USD 0 0 2022-06



Neurocrine Biosciences Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.